Technology movement Where longevity ideas are becoming inventions. Patent records reveal where protection is being sought for technologies. They do not show that an invention works, is safe, has been commercialized, or is legally available to use.
Invention disclosed Patent publication Research & trials
1,125 Patent records
471 Published in the last year
20 Patent offices represented
96 Longevity topics connected
Application publication visible WO2026206274A1
HUMANIS SAGLIK A S [TR] · HUMANIS SAĞLIK A.Ş.
Earliest priority March 28, 2025
Patent offices 1
Family publications 1 Open the source-linked record → Application publication visible EP4808529A1
ABDI IBRAHIM ILAC SANAYI VE TICARET ANONIM SIRKETI [TR] · Abdi Ibrahim Ilac Sanayi ve Ticaret Anonim Sirketi
Earliest priority November 15, 2023
Patent offices 1
Family publications 1 Open the source-linked record → Application publication visible EP4799686A1
SANOVEL ILAC SANAYI VE TICARET ANONIM SIRKETI [TR] · Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi
Earliest priority February 28, 2025
Patent offices 1
Family publications 1 Open the source-linked record → Application publication visible KR20260122692A
CHONG KUN DANG PHARMACEUTICAL CORP [KR] · 주식회사 종근당
Earliest priority February 5, 2025
Patent offices 1
Family publications 1 Open the source-linked record → Application publication visible CN122461574A
UNIV SOOCHOW · 苏州大学
Earliest priority June 30, 2026
Patent offices 1
Family publications 1 Open the source-linked record → Application publication visible CN122461336A
UNIV TSINGHUA · 清华大学
Earliest priority June 5, 2026
Patent offices 1
Family publications 1 Open the source-linked record → Application publication visible WO2026149370A1
SHENZHEN JINGTAI TECH CO LTD [CN] · 深圳晶泰科技有限公司
Earliest priority January 7, 2025
Patent offices 1
Family publications 1 Open the source-linked record → Application publication visible CN122376549A
HEBEI CHEMICAL & PHARMACEUTICAL COLLEGE · 河北化工医药职业技术学院
Earliest priority June 4, 2026
Patent offices 1
Family publications 1 Open the source-linked record → Application publication visible CN122351184A
SHANDONG SBOND PHARMACEUTICAL CO LTD · 山东司邦得制药有限公司
Earliest priority June 9, 2026
Patent offices 1
Family publications 1 Open the source-linked record → Application publication visible WO2026147441A1
ALI RAIF ILAC SANAYI ANONIM SIRKETI [TR] · ALI RAIF ILAC SANAYI ANONIM SIRKETI
Earliest priority December 30, 2024
Patent offices 1
Family publications 1 Open the source-linked record → Application publication visible CN122320932A
FIRST HOSPITAL OF SHANXI MEDICAL UNIV · 山西医科大学第一医院
Earliest priority June 8, 2026
Patent offices 1
Family publications 1 Open the source-linked record → Publication stage not classified CN224404986U
JIANGSU XIANGRUI PHARMACEUTICAL CO LTD · 江苏祥瑞药业有限公司
Earliest priority June 4, 2025
Patent offices 1
Family publications 1 Open the source-linked record → Application publication visible CN122272580A
XINSHI YANGGUANG PHARMACEUTICAL HEBEI CO LTD · 新石阳光药业(河北)有限公司
Earliest priority May 28, 2026
Patent offices 1
Family publications 1 Open the source-linked record → Application publication visible KR20260095971A
HANMI PHARMACEUTICAL CO LTD [KR] · 한미약품 주식회사
Earliest priority December 17, 2024
Patent offices 1
Family publications 1 Open the source-linked record → Application publication visible KR20260096778A
MEDI&SHARE INC [KR] · 주식회사 메디앤쉐어
Earliest priority December 17, 2024
Patent offices 1
Family publications 1 Open the source-linked record → Application publication visible CN122251428A
THE SECOND HOSPITAL OF TIANJIN MEDICAL UNIV · TIANJIN MEDICAL UNIV GENERAL HOSPITAL · TIANJIN MEDICAL UNIV ZHUXIAN MEMORIAL HOSPITAL TIANJIN MEDICAL UNIV METABOLIC HOSPITAL TIANJIN DAIXI
Earliest priority May 27, 2026
Patent offices 1
Family publications 1 Open the source-linked record → Application publication visible CN122259739A
HENAN DAXIN PHARMACEUTICAL CO LTD · 河南大新药业有限公司
Earliest priority March 16, 2026
Patent offices 1
Family publications 1 Open the source-linked record → Publication stage not classified CN224398778U
HARBIN TONGYITANG PHARMACEUTICAL CO LTD · 哈尔滨同一堂药业有限公司
Earliest priority September 1, 2025
Patent offices 1
Family publications 1 Open the source-linked record → Application publication visible CN122233363A
UNIV SICHUAN · 四川大学
Earliest priority May 8, 2026
Patent offices 1
Family publications 1 Open the source-linked record → Application publication visible WO2026127322A1
DAEWOONG THERAPEUTICS INC [KR] · 주식회사 대웅테라퓨틱스
Earliest priority December 11, 2024
Patent offices 1
Family publications 1 Open the source-linked record → Application publication visible CN122182528A
THE FIRST AFFILIATED HOSPITAL OF ZHEJIANG UNIV COLLEGE OF MEDICINE THE FIRST HOSPITAL OF ZHEJIANG PR · 浙江大学医学院附属第一医院(浙江省第一医院)
Earliest priority March 18, 2026
Patent offices 1
Family publications 1 Open the source-linked record → Application publication visible CN122163595A
QINGDAO HUANGHAI PHARMACEUTICAL CO LTD · 青岛黄海制药有限责任公司
Earliest priority December 9, 2024
Patent offices 1
Family publications 1 Open the source-linked record → Application publication visible CN122075608A
CHONGQING CONQUER PHARMACEUTICAL CO LTD · 重庆康刻尔制药股份有限公司
Earliest priority March 31, 2026
Patent offices 1
Family publications 1 Open the source-linked record → Application publication visible CN121896175A
BOYALIFE INC · 博雅干细胞科技有限公司
Earliest priority December 30, 2025
Patent offices 1
Family publications 1 Open the source-linked record → What Patent Radar can—and cannot—tell you A patent application is a public claim to an invention, not peer-reviewed evidence, regulatory approval, freedom-to-operate advice, a legal-status opinion, or proof of effectiveness. Privacy-minimal publication and application records must not be read as complete worldwide patent families.
Sources: European Patent Office Open Patent Services and Publication Server, Canadian Intellectual Property Office ST.96 releases, and IP Australia IP RAPID under CC BY 4.0. OPS supplies worldwide family context while national feeds provide privacy-minimal source records. Bibliographic metadata is transformed by immortal.life; no endorsement is implied.